Breast Recurrence Score Test Market Size & Share, by Type (Oncotype, MammaPrint), End User (Hospitals, Diagnostic Laboratories, Research Institutions) - Global Supply & Demand Analysis & Growth Forecasts, Statistics Report 2024-2036

  • Report ID: 5394
  • Published Date: Nov 24, 2023
  • Report Format: PDF, PPT

Companies Dominating the Breast Recurrence Score Test Landscape

top-features-companies
    • Genomic Health, Inc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Agendia, Inc.
    • NanoString Technologies, Inc.
    • Myriad Genetics, Inc.
    • Thermo Fisher Scientific, Inc.
    • Illumina, Inc.
    • Roche Holdings AG
    • Biotheranostics, Inc.
    • Qiagen N.V.
    • Veracyte, Inc.

Browse Key Market Insights with Data Illustration:

In-the-news

In The News

  • Agendia acquired Biomedex, a privately held molecular diagnostics company developing novel multi-cancer detection assays using liquid biopsy technology. This acquisition is expected to expand Agendia's portfolio of cancer diagnostic tests and increase its presence in the liquid biopsy market.
  • Agendia received FDA approval for its ColonPrint blood test, a liquid biopsy assay that is used to detect early-stage colon cancer. This approval marks a significant milestone for Agendia as it expands its product portfolio and offers a minimally invasive option for colon cancer screening.

Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 5394
  • Published Date: Nov 24, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Increasing demand for healthcare sector is the major factor driving the market growth.

The market size of breast recurrence score test is anticipated to attain a CAGR of 8% over the forecast period, i.e., 2024-2036.

The major players in the market Genomic Health, Inc., Agendia, Inc., NanoString Technologies, Inc., Myriad Genetics, Inc., Thermo Fisher Scientific, Inc., Illumina, Inc., and others.

The hospitals segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.

The market in the Asia Pacific region is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.
Inquiry Before Buying Request Free Sample
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying